BACKGROUND: Several lines of evidence support a pathophysiological role of immunity in atherosclerosis. Tyrosine-nitrated proteins, a footprint of oxygen- and nitrogen-derived oxidants generated by cells of the immune system, are enriched in atheromatous lesions and in circulation of patients with coronary artery disease (CAD). However, the consequences of possible immune reactions triggered by the presence of nitrated proteins in subjects with clinically documented atherosclerosis have not been explored. METHODS AND RESULTS: Specific immunoglobulins that recognize 3-nitrotyrosine epitopes were identified in human lesions, as well as in circulation of patients with CAD. The levels of circulating immunoglobulins against 3-nitrotyrosine epitopes were quantified in patients with CAD (n=374) and subjects without CAD (non-CAD controls, n=313). A 10-fold increase in the mean level of circulating immunoglobulins against protein-bound 3-nitrotyrosine was documented in patients with CAD (3.75±1.8 μg antibody Eq/mL plasma versus 0.36±0.8 μg antibody Eq/mL plasma), and was strongly associated with angiographic evidence of significant CAD. CONCLUSIONS: The results of this cross-sectional study suggest that posttranslational modification of proteins via nitration within atherosclerotic plaque-laden arteries and in circulation serve as neo-epitopes for the elaboration of immunoglobulins, thereby providing an association between oxidant production and the activation of the immune system in CAD.
BACKGROUND: Several lines of evidence support a pathophysiological role of immunity in atherosclerosis. Tyrosine-nitrated proteins, a footprint of oxygen- and nitrogen-derived oxidants generated by cells of the immune system, are enriched in atheromatous lesions and in circulation of patients with coronary artery disease (CAD). However, the consequences of possible immune reactions triggered by the presence of nitrated proteins in subjects with clinically documented atherosclerosis have not been explored. METHODS AND RESULTS: Specific immunoglobulins that recognize 3-nitrotyrosine epitopes were identified in human lesions, as well as in circulation of patients with CAD. The levels of circulating immunoglobulins against 3-nitrotyrosine epitopes were quantified in patients with CAD (n=374) and subjects without CAD (non-CAD controls, n=313). A 10-fold increase in the mean level of circulating immunoglobulins against protein-bound 3-nitrotyrosine was documented in patients with CAD (3.75±1.8 μg antibody Eq/mL plasma versus 0.36±0.8 μg antibody Eq/mL plasma), and was strongly associated with angiographic evidence of significant CAD. CONCLUSIONS: The results of this cross-sectional study suggest that posttranslational modification of proteins via nitration within atherosclerotic plaque-laden arteries and in circulation serve as neo-epitopes for the elaboration of immunoglobulins, thereby providing an association between oxidant production and the activation of the immune system in CAD.
Authors: Christoph J Binder; Mi-Kyung Chang; Peter X Shaw; Yury I Miller; Karsten Hartvigsen; Asheesh Dewan; Joseph L Witztum Journal: Nat Med Date: 2002-11 Impact factor: 53.440
Authors: Mehdi H Shishehbor; Ronnier J Aviles; Marie-Luise Brennan; Xiaoming Fu; Marlene Goormastic; Gregory L Pearce; Noyan Gokce; John F Keaney; Marc S Penn; Dennis L Sprecher; Joseph A Vita; Stanley L Hazen Journal: JAMA Date: 2003-04-02 Impact factor: 56.272
Authors: S L Hazen; R Zhang; Z Shen; W Wu; E A Podrez; J C MacPherson; D Schmitt; S N Mitra; C Mukhopadhyay; Y Chen; P A Cohen; H F Hoff; H M Abu-Soud Journal: Circ Res Date: 1999-11-12 Impact factor: 17.367
Authors: P X Shaw; S Hörkkö; S Tsimikas; M K Chang; W Palinski; G J Silverman; P P Chen; J L Witztum Journal: Arterioscler Thromb Vasc Biol Date: 2001-08 Impact factor: 8.311
Authors: M D Gole; J M Souza; I Choi; C Hertkorn; S Malcolm; R F Foust; B Finkel; P N Lanken; H Ischiropoulos Journal: Am J Physiol Lung Cell Mol Physiol Date: 2000-05 Impact factor: 5.464
Authors: B I Giasson; J E Duda; I V Murray; Q Chen; J M Souza; H I Hurtig; H Ischiropoulos; J Q Trojanowski; V M Lee Journal: Science Date: 2000-11-03 Impact factor: 47.728
Authors: Diana M Fries; Evgenia Paxinou; Marios Themistocleous; Eric Swanberg; Kathy K Griendling; Daniela Salvemini; Jan W Slot; Harry F G Heijnen; Stanley L Hazen; Harry Ischiropoulos Journal: J Biol Chem Date: 2003-04-10 Impact factor: 5.157
Authors: Sonia R Salvatore; Dario A Vitturi; Paul R S Baker; Gustavo Bonacci; Jeffrey R Koenitzer; Steven R Woodcock; Bruce A Freeman; Francisco J Schopfer Journal: J Lipid Res Date: 2013-04-25 Impact factor: 5.922
Authors: Kira Ziegler; Anna T Kunert; Kathrin Reinmuth-Selzle; Anna Lena Leifke; Darius Widera; Michael G Weller; Detlef Schuppan; Janine Fröhlich-Nowoisky; Kurt Lucas; Ulrich Pöschl Journal: Redox Biol Date: 2020-07-20 Impact factor: 11.799